Congenital falciparum malaria
ICD-10 P37.3 is a billable code used to indicate a diagnosis of congenital falciparum malaria.
Congenital falciparum malaria is a severe form of malaria caused by the Plasmodium falciparum parasite, which can be transmitted from an infected mother to her fetus during pregnancy. This condition can lead to significant morbidity and mortality in newborns, manifesting as anemia, low birth weight, and respiratory distress. The clinical presentation may vary, with some infants showing no symptoms at birth while others may develop severe illness shortly after delivery. Diagnosis is typically confirmed through blood smears or rapid diagnostic tests. Management includes supportive care and antimalarial treatment, which is crucial to prevent complications. Early identification and treatment are essential to improve outcomes for affected infants. Congenital malaria is a rare but serious condition that requires careful monitoring and intervention in the neonatal period.
Detailed maternal history, including malaria status and treatment during pregnancy, and newborn clinical assessments.
Infants presenting with anemia, jaundice, or respiratory distress in the NICU.
Close monitoring for complications such as hypoglycemia and the need for prompt treatment initiation.
Comprehensive follow-up documentation to monitor growth and development in infants diagnosed with congenital malaria.
Pediatric visits for infants with a history of congenital malaria presenting with developmental delays or recurrent infections.
Awareness of potential long-term effects of congenital malaria on health and development.
Used to confirm malaria diagnosis in newborns with suspected congenital malaria.
Document the indication for testing and results in the medical record.
Neonatologists should ensure that testing is performed promptly to guide treatment.
Key symptoms include anemia, jaundice, respiratory distress, and low birth weight. Some infants may be asymptomatic at birth but can develop symptoms shortly after.
